Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Cas No. | 1258595-14-0 |
|---|---|
| Purity | ≥99% |
| Formula | C29H32F2N3O7P |
| Formula Wt. | 603.56 |
| IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
| Synonym | LHC165 |
| Appearance | Pale yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Inhibitor of PI3K.
Melatonin analog; MT1/2 agonist, 5-HT2C antagon...
Flavonoid found in Epimedium.
Aminoglycoside; protein translation inhibitor, ...
Islet α/β cell proliferation stimulator.
CDK4/6 inhibitor.
Peptide fragment of HER2/neu/erbB2 receptor.
EGFR inhibitor.
Iridoid glucoside found in Eucommia, Castilleja...
Topoisomerase II inhibitor, RPA modulator.
Prodrug
Endogenous neuropeptide hormone; somatostatin a...
Sesquiterpene found in Nidula.
Vitamin A derivative; RAR and RXR agonist.
CDK inhibitor.
Neuroprotective flavonoid
Endogenous tachykinin peptide, involved in infl...
Phenyl hydrazide; neuronal oxidative stress inh...
Synthetic hydrocortisone derivative; glucocorti...
Organosulfur found in garlic.